Scalper1 News
Big pharma Pfizer (PFE) fulfilled weeks of rumors Monday as it announced that it’s acquiring specialty-drug giant Allergan (AGN) in an all-stock deal valued at $160 billion. Pfizer agreed to provide Allergan shareholders with 11.3 Pfizer shares for each Allergan share, which based on Friday’s closing price values Allergan at $363.63 a share. This was somewhat lower than last week’s anonymously sourced press reports pegging the price at $370 to Scalper1 News
Scalper1 News